![]() |
市場調查報告書
商品編碼
2040943
超音波設備市場預測至2034年-按產品類型、顯示類型、便攜性、連接方式、應用、最終用戶和地區分類的全球分析Ultrasound Devices Market Forecasts to 2034 - Global Analysis By Product (Therapeutic Ultrasound, Diagnostic Ultrasound and Other Products), Display Type, Portability, Connectivity, Application, End User and By Geography |
||||||
根據 Stratistics MRC 預測,全球超音波設備市場預計到 2026 年將達到 108 億美元,並在預測期內以 8.3% 的複合年成長率成長,到 2034 年達到 204.9 億美元。
超音波設備是一種利用高頻聲波即時成像人體內部結構的醫療設備。這些非侵入性設備因其能夠顯示器官、組織和血流情況而被廣泛用於診斷。超音波技術透過發射聲波並接收其反射,可以檢查各種疾病,幫助醫療專業人員做出準確診斷並制定治療方案。由於其安全性高、用途廣泛且在軟組織影像方面效果顯著,超音波設備廣泛應用於婦產科、循環系統和其他醫學專科。
根據美國心臟協會(AHA)的數據,2020年光是美國就有超過1.027億成年人至少有一種心血管疾病。預計到2035年,這一數字將增加至1.312億。心臟病每年對美國政府造成的損失約2,190億美元。
慢性病盛行率增加
隨著心血管疾病、癌症和肌肉骨骼疾病發病率的不斷上升,對超音波設備等先進診斷工具的需求日益成長。這些設備在慢性疾病的早期發現、後續觀察和治療方案製定中發揮著至關重要的作用,從而推動了市場成長。超音波技術的不斷進步為醫療專業人員提供了更精準、更有效率的診斷能力,進一步促進了市場擴張。
影像品質和診斷方面的挑戰
操作者技能水準的差異會影響影像擷取的一致性,並導致診斷結果不一致。組織邊界和體形會產生偽影,妨礙準確判讀。此外,技術限制可能導致無法獲得精確診斷所需的解析度。市場在影像品質和判讀方面面臨許多挑戰,這些挑戰源自於操作者依賴性、組織偽影以及肥胖患者滲透性不足等因素。
醫療費用增加
慢性病盛行率的上升和人口老化推動了超音波設備需求的成長。這些設備提供無創且經濟高效的診斷解決方案,促進了其在全球的普及。此外,超音波設備在產科、循環系統和肌肉骨骼成像等領域的應用不斷擴展,也促進了市場成長。然而,先進超音波技術的研發和製造成本不斷攀升,導致醫療保健市場整體支出增加。
設備高成本
設備高成本仍然是市場上的一大挑戰。先進的技術、複雜的製造流程和持續的創新都推高了生產成本。嚴格的監管要求和品質標準進一步增加了製造成本。高成本阻礙了設備的廣泛應用,尤其是在資源匱乏的環境中,限制了人們獲得這種重要的診斷工具。
新冠疫情對市場產生了重大影響。儘管由於超音波設備在診斷病毒相關呼吸系統併發症發揮關鍵作用,市場需求有所成長,但同時也面臨供應鏈中斷和擇期手術延遲等挑戰。疫情加速了攜帶式和照護現場(POC)超音波設備的普及,從而實現了快速高效的診斷。儘管初期面臨許多不利因素,超音波設備市場正在適應不斷變化的醫療保健格局,創新和技術進步正在推動其復甦和未來的成長。
在預測期內,診斷超音波市場預計將成為最大的細分市場。
在預測期內,診斷超音波領域預計將佔據最大的市場佔有率。這項非侵入性成像技術利用高頻聲波即時成像體內結構。市場成長的驅動力包括技術進步、慢性病盛行率上升以及對即時診斷需求的不斷成長。持續的創新使超音波設備更加便攜、易於使用且功能更加多樣化,從而促進了其在各個醫療專科領域的廣泛應用。
預計在預測期內,藍牙細分市場將呈現最高的複合年成長率。
預計在預測期內,藍牙細分市場將呈現最高的複合年成長率。這項技術創新實現了超音波設備與其他設備之間的無縫連接和高效數據傳輸。這項進步不僅將提升整體使用者體驗,也將有助於推動即時診斷技術的發展。在對更高效、更互聯的醫療解決方案日益成長的需求驅動下,超音波設備中的藍牙市場持續擴張。
預計北美將在預測期內佔據最大的市場佔有率。對可攜式和小型超音波設備日益成長的需求推動了即時診斷的發展。此外,人口老化也促進了市場擴張,因為超音波診斷在各種醫療應用中已廣泛應用。該地區的領導者正專注於產品創新和策略聯盟,進一步推動超音波設備市場的蓬勃發展。
亞太地區預計將在預測期內維持最高的複合年成長率,這主要得益於醫療基礎設施的改善和對診斷影像服務需求的成長。技術進步和人口老化也推動了市場擴張。在醫療現代化進程的持續推進和慢性病高發生率的背景下,預計該市場將繼續保持成長勢頭。
According to Stratistics MRC, the Global Ultrasound Devices Market is accounted for $10.80 billion in 2026 and is expected to reach $20.49 billion by 2034 growing at a CAGR of 8.3% during the forecast period. Ultrasound devices are medical tools that utilize high-frequency sound waves to produce real-time images of internal structures within the body. These non-invasive devices are commonly employed for diagnostic purposes, enabling visualization of organs, tissues, and blood flow. By emitting sound waves and capturing their reflections, ultrasound technology facilitates the examination of various medical conditions, aiding healthcare professionals in accurate diagnoses and treatment planning. Ultrasound devices are widely used in obstetrics, cardiology, and other medical specialties due to their safety, versatility, and effectiveness in imaging soft tissues.
According to the American Heart Association (AHA), in the US alone, more than 102.7 million adults had at least one cardiovascular condition as of 2020. This number is projected to rise to 131.2 million by 2035. Heart disease costs the US government about USD 219 billion each year.
Rising prevalence of chronic diseases
The increasing incidence of conditions such as cardiovascular diseases, cancer, and musculoskeletal disorders has led to a growing need for advanced diagnostic tools like ultrasound devices. These devices play a crucial role in early detection, monitoring, and treatment planning for chronic illnesses, thereby driving market growth. The continuous technological advancements in ultrasound technology further contribute to the market's expansion, providing more accurate and efficient diagnostic capabilities for healthcare professionals.
Challenges in image quality and interpretation
Operator skill variations can impact the consistency of image acquisition, leading to diagnostic discrepancies. Tissue interfaces and body habitus can generate artifacts, hindering accurate interpretation. Additionally, technological limitations may hinder the resolution needed for precise diagnostics. The market faces challenges in image quality and interpretation, stemming from factors such as operator dependence, tissue artifacts, and limited penetration in obese patients.
Rising healthcare expenditure
The rising prevalence of chronic diseases, coupled with a growing aging population, is amplifying the need for ultrasound devices. These devices offer non-invasive and cost-effective diagnostic solutions, fueling their adoption globally. Additionally, expanding applications in obstetrics, cardiology, and musculoskeletal imaging contribute to market growth. However, the escalating costs associated with research, development, and manufacturing of advanced ultrasound technologies contribute to the overall increase in healthcare expenditure within the market.
High cost of equipment
The high cost of equipment remains a significant challenge in the market. The advanced technology, intricate manufacturing processes, and constant innovation contribute to elevated production expenses. Stringent regulatory requirements and quality standards further increase manufacturing costs. The high cost poses a barrier to widespread adoption, particularly in resource-constrained settings, limiting accessibility to this critical diagnostic tool.
The COVID-19 pandemic has significantly impacted the market. While the demand for ultrasound devices increased due to their crucial role in diagnosing respiratory complications associated with the virus, the market faced challenges such as disrupted supply chains and delayed elective procedures. The pandemic accelerated the adoption of portable and point-of-care ultrasound devices for quick and efficient diagnostics. Despite initial setbacks, the ultrasound devices market is adapting to the evolving healthcare landscape, with innovations and technological advancements shaping its recovery and future growth.
The diagnostic ultrasound segment is expected to be the largest during the forecast period
The diagnostic ultrasound segment is expected to be the largest during the forecast period. This non-invasive imaging technology utilizes high-frequency sound waves to create real-time images of internal body structures. The market's growth is propelled by technological advancements, increasing prevalence of chronic diseases, and the rising demand for point-of-care diagnostics. With continuous innovation, ultrasound devices are becoming more portable, user-friendly, and versatile, driving their widespread adoption across diverse medical specialties.
The bluetooth segment is expected to have the highest CAGR during the forecast period
The bluetooth segment is expected to have the highest CAGR during the forecast period. This innovation enables seamless connectivity, facilitating efficient data transfer between ultrasound machines and other devices. This development not only improves the overall user experience but also contributes to the advancement of point-of-care diagnostics. The Bluetooth in ultrasound devices market continues to expand, driven by the growing demand for streamlined and interconnected healthcare solutions.
North America is projected to hold the largest market share during the forecast period. The demand for portable and compact ultrasound devices is rising, facilitating point-of-care diagnostics. Additionally, a growing aging population contributes to the market expansion, as ultrasound is widely used in various medical applications. Key players in the region are focusing on product innovation and strategic collaborations, further fueling market development in the ultrasound devices sector.
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to increased healthcare infrastructure development and rising demand for diagnostic imaging services. Advancements in technology, coupled with a growing aging population, contribute to the expanding market. The market's trajectory is expected to remain upward, propelled by ongoing healthcare modernization efforts and the prevalence of chronic diseases.
Key players in the market
Some of the key players in Ultrasound Devices market include GE HealthCare, Canon Inc., Analogic Corporation, Fujifilm Holdings Corporation , Samsung Medison Co., Ltd., Toshiba Medical Systems Corporation, Siemens Healthineers AG, Philips Healthcare, Hitachi, Ltd., Mindray Bio-Medical Electronics Co., Ltd., Alpinion Medical Systems Co., Ltd., Supersonic Imagine, Trivitron Healthcare,, Terason Corporation, Exact Imaging Inc. and Medical Technologies Co.
In February 2023, GE HealthCare has acquired Caption Health, thereby expanding the capabilities of ultrasound technology to assist new users through FDA-cleared, AI-powered image guidance. By leveraging Caption AI applications, ultrasound examinations can be streamlined, accelerating the process and empowering a wider range of healthcare professionals to perform fundamental echocardiogram exams.
In November 2022, Canon Inc. revealed its plans to form a new subsidiary called Canon Healthcare USA, Inc. With this strategic move, Canon intends to enhance its position within the influential American medical market and expedite the expansion of its medical business.
In October 2022, Fujifilm corporation, received regulatory approval for its latest generation endoscopic ultrasound endoscope (EG-740UT) and achieves compatibility of its ultrasound endoscope line-up with the flagship ARIETTA Ultrasound system of Fujifilm Healthcare.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.